First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Sees Unusually-High Trading Volume – Here’s What Happened

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH – Get Free Report) saw unusually-high trading volume on Tuesday . Approximately 380,568 shares were traded during mid-day trading, an increase of 57% from the previous session’s volume of 241,641 shares.The stock last traded at $38.58 and had previously closed at $38.59.

First Trust Nasdaq Pharmaceuticals ETF Trading Up 0.3%

The stock has a market cap of $869.26 million, a P/E ratio of 14.51 and a beta of 0.45. The stock’s fifty day moving average price is $37.21 and its 200 day moving average price is $35.29.

Get First Trust Nasdaq Pharmaceuticals ETF alerts:

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Thursday, June 25th were given a dividend of $0.092 per share. The ex-dividend date was Thursday, June 25th. This is a positive change from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.06. This represents a $0.37 dividend on an annualized basis and a yield of 1.0%.

Hedge Funds Weigh In On First Trust Nasdaq Pharmaceuticals ETF

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Vivaldi Capital Management LP increased its position in shares of First Trust Nasdaq Pharmaceuticals ETF by 16.0% during the 1st quarter. Vivaldi Capital Management LP now owns 12,590 shares of the company’s stock valued at $433,000 after purchasing an additional 1,741 shares during the last quarter. OLD Mission Capital LLC bought a new stake in First Trust Nasdaq Pharmaceuticals ETF in the 4th quarter worth approximately $528,000. Kestra Advisory Services LLC bought a new stake in First Trust Nasdaq Pharmaceuticals ETF in the 4th quarter worth approximately $59,000. Commonwealth Equity Services LLC purchased a new stake in First Trust Nasdaq Pharmaceuticals ETF in the fourth quarter worth approximately $237,000. Finally, LPL Financial LLC boosted its stake in First Trust Nasdaq Pharmaceuticals ETF by 40.5% in the fourth quarter. LPL Financial LLC now owns 146,105 shares of the company’s stock worth $4,813,000 after buying an additional 42,147 shares in the last quarter.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

(Get Free Report)

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.

Featured Articles

• Five stocks we like better than First Trust Nasdaq Pharmaceuticals ETF
• Reddit’s U.S. User Decline Raises a Bigger Question After Its Earnings Beat
• Marriott’s Earnings Drop May Be Missing the Bigger Fee Growth Story
• Apple’s AI Strategy Looks Different—Will It Pay Off?
• The AI Chip Stock Making a Quiet Move Toward Dominance

Receive News & Ratings for First Trust Nasdaq Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust Nasdaq Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.